{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:55:06Z","timestamp":1768553706392,"version":"3.49.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosom Med"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Several studies have reported an association between nonceliac gluten sensitivity and schizophrenia. Immune and kynurenine (KYN) pathways have also been implicated in the pathophysiology of schizophrenia, and certain proinflammatory immune mediators may increase KYN and reduce tryptophan (TRP) levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We measured serum antigliadin immunoglobulin G (IgG), KYN, and TRP in 950 patients with schizophrenia. Patients with antibody level at the 90th percentile or higher of control participants (21.9% of all patients) were classified as having elevated antigliadin IgG. Independent <jats:italic toggle=\"yes\">t<\/jats:italic> tests and linear regression models were used to compare TRP, KYN, and KYN-TRP ratio (indicator of TRP metabolism) between patients with and those without elevated antigliadin IgG. The correlation between antigliadin IgG and TRP, KYN, and the ratio was also evaluated in the patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>KYN and KYN-TRP ratio were higher in patients with elevated antigliadin IgG (geometric mean [standard deviation {SD}] = 2.65 [0.25] \u00b5mol\/L versus 2.25 [0.23] \u00b5mol\/L [<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001] and 0.05 [0.26] versus 0.04 [0.25; <jats:italic toggle=\"yes\">p<\/jats:italic> = .001] respectively), findings robust to adjustment for potential demographic and clinical confounders. Antigliadin IgG positively correlated with KYN and KYN-TRP ratio (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.12, <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .001; <jats:italic toggle=\"yes\">r<\/jats:italic> = 0.11, <jats:italic toggle=\"yes\">p<\/jats:italic> = .002). TRP did not differ between the two groups and did not correlate with antigliadin IgG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results connect nonceliac gluten sensitivity with the KYN pathway of TRP metabolism in psychotic illness and hint toward potential individualized treatment targets.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/psy.0000000000000352","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T11:40:09Z","timestamp":1467632409000},"page":"931-939","source":"Crossref","is-referenced-by-count":25,"title":["Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies"],"prefix":"10.1097","volume":"78","author":[{"given":"Olaoluwa","family":"Okusaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Giegling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette M.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Konte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Friedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Groer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Stearns-Yoder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janardan P.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Hoisington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William W.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodor T.","family":"Postolache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230824","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/schbul\/sbp055","article-title":"Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population","volume":"37","year":"2011","journal-title":"Schizophr Bull"},{"key":"bib2-20230824","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biopsych.2010.03.021","article-title":"Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia","volume":"68","year":"2010","journal-title":"Biol Psychiatry"},{"key":"bib3-20230824","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/15622975.2012.747699","article-title":"Elevated gliadin antibody levels in individuals with schizophrenia","volume":"14","year":"2013","journal-title":"World J Biol Psychiatry"},{"key":"bib4-20230824","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0006-3223(94)00176-4","article-title":"Specific IgA antibody increases in schizophrenia","volume":"37","year":"1995","journal-title":"Biol Psychiatry"},{"key":"bib5-20230824","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1176\/appi.ajp.2012.11081197","article-title":"Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring","volume":"169","year":"2012","journal-title":"Am J Psychiatry"},{"key":"bib6-20230824","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/bmj.328.7437.438","article-title":"Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers","volume":"328","year":"2004","journal-title":"BMJ"},{"key":"bib7-20230824","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0447.2005.00687.x","article-title":"The gluten connection: the association between schizophrenia and celiac disease","volume":"113","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"bib8-20230824","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/00365520600863472","article-title":"Coeliac disease and risk of schizophrenia and other psychosis: a general population cohort study","volume":"42","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"bib9-20230824","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.schres.2009.08.009","article-title":"Novel immune response to gluten in individuals with schizophrenia","volume":"118","year":"2010","journal-title":"Schizophr Res"},{"key":"bib10-20230824","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bpg.2015.04.006","article-title":"Non-celiac gluten sensitivity: a work-in-progress entity in the spectrum of wheat-related disorders","volume":"29","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"bib11-20230824","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1871527314666150202152436","article-title":"Non-celiac gluten sensitivity triggers gut dysbiosis, neuroinflammation, gut-brain axis dysfunction, and vulnerability for dementia","volume":"14","year":"2015","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"bib12-20230824","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13317-014-0064-0","article-title":"Celiac and non-celiac gluten sensitivity: a review on the association with schizophrenia and mood disorders","volume":"5","year":"2014","journal-title":"Auto Immun Highlights"},{"key":"bib13-20230824","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.schres.2014.09.023","article-title":"Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia","volume":"159","year":"2014","journal-title":"Schizophr Res"},{"key":"bib14-20230824","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2014.04.041","article-title":"Neuroinflammation and white matter pathology in schizophrenia: systematic review","volume":"161","year":"2015","journal-title":"Schizophr Res"},{"key":"bib15-20230824","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biopsych.2013.12.002","article-title":"The cytokine model of schizophrenia: emerging therapeutic strategies","volume":"75","year":"2014","journal-title":"Biol Psychiatry"},{"key":"bib16-20230824","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","year":"2011","journal-title":"Biol Psychiatry"},{"key":"bib17-20230824","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/schbul\/sbv063","article-title":"The kraepelinian dichotomy from the perspective of prenatal infectious and immunologic insults","volume":"41","year":"2015","journal-title":"Schizophr Bull"},{"key":"bib18-20230824","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1176\/appi.ajp.2012.12060735","article-title":"Celiac disease and schizophrenia","volume":"169","year":"2012","journal-title":"Am J Psychiatry"},{"key":"bib19-20230824","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1176\/appi.ajp.2013.13010086","article-title":"A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis","volume":"171","year":"2014","journal-title":"Am J Psychiatry"},{"key":"bib20-20230824","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biopsych.2013.10.003","article-title":"Major histocompatibility complex I in brain development and schizophrenia","volume":"75","year":"2014","journal-title":"Biol Psychiatry"},{"key":"bib21-20230824","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/296158a0","article-title":"Two genetic loci control the murine immune response to A-gliadin, a wheat protein that activates coeliac sprue","volume":"296","year":"1982","journal-title":"Nature"},{"key":"bib22-20230824","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/14656566.2015.1032248","article-title":"Drug repurposing and emerging adjunctive treatments for schizophrenia","volume":"16","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"bib23-20230824","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/schbul\/sbq086","article-title":"Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia","volume":"38","year":"2012","journal-title":"Schizophr Bull"},{"key":"bib24-20230824","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","year":"2001","journal-title":"Biol Psychiatry"},{"key":"bib25-20230824","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","year":"2001","journal-title":"Neurosci Lett"},{"key":"bib26-20230824","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","year":"2011","journal-title":"Schizophr Bull"},{"key":"bib27-20230824","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"bib28-20230824","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2045125314557797","article-title":"Drug models of schizophrenia","volume":"5","year":"2015","journal-title":"Ther Adv Psychopharmacol"},{"key":"bib29-20230824","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/mp.2013.136","article-title":"Imaging glutamate in schizophrenia: review of findings and implications for drug discovery","volume":"19","year":"2014","journal-title":"Mol Psychiatry"},{"key":"bib30-20230824","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.physbeh.2007.05.025","article-title":"The kynurenic acid hypothesis of schizophrenia","volume":"92","year":"2007","journal-title":"Physiol Behav"},{"key":"bib31-20230824","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/PSY.0b013e318268de9f","article-title":"Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway","volume":"74","year":"2012","journal-title":"Psychosom Med"},{"key":"bib32-20230824","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/prilozi-2015-0042","article-title":"Serum cortisol and DHEA-S levels in schizophrenic patients with different response to antipsychotic therapy: association with psychopathology","volume":"36","year":"2015","journal-title":"Prilozi"},{"key":"bib34-20230824","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","year":"1987","journal-title":"Schizophr Bull"},{"key":"bib35-20230824","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/clinchem\/43.12.2424","article-title":"Simultaneous measurement of serum tryptophan and kynurenine by HPLC","volume":"43","year":"1997","journal-title":"Clin Chem"},{"key":"bib36-20230824","article-title":"Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling","year":"2014","journal-title":"Schizophr Res"},{"key":"bib37-20230824","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2249.2007.03365.x","article-title":"Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease","volume":"148","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"bib38-20230824","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00964611","article-title":"l-kynurenine: its synthesis and possible regulatory function in brain","volume":"5","year":"1980","journal-title":"Neurochem Res"},{"key":"bib39-20230824","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","year":"1982","journal-title":"Brain Res"},{"key":"bib40-20230824","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12031-009-9235-2","article-title":"The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex","volume":"40","year":"2010","journal-title":"J Mol Neurosci"},{"key":"bib41-20230824","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archgenpsychiatry.2011.71","article-title":"Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes","volume":"68","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"bib42-20230824","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/schbul\/sbs100","article-title":"Twenty-five years of glutamate in schizophrenia: are we there yet?","volume":"38","year":"2012","journal-title":"Schizophr Bull"},{"key":"bib43-20230824","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","year":"2006","journal-title":"J Immunol"},{"key":"bib44-20230824","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1432-2277.2004.00031.x","article-title":"Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo","volume":"18","year":"2005","journal-title":"Transpl Int"},{"key":"bib45-20230824","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4615-0135-0_3","article-title":"Tryptophan catabolism and T cell responses","volume":"527","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"bib46-20230824","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbl050","article-title":"Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis","volume":"33","year":"2007","journal-title":"Schizophr Bull"},{"key":"bib47-20230824","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0269881112467089","article-title":"A review of anti-inflammatory agents for symptoms of schizophrenia","volume":"27","year":"2013","journal-title":"J Psychopharmacol"},{"key":"bib48-20230824","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pnpbp.2012.11.008","article-title":"Anti-inflammatory treatment in schizophrenia","volume":"42","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"bib49-20230824","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.pnpbp.2004.05.047","article-title":"Th1, Th2 and Th3 cytokine alteration in schizophrenia","volume":"28","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"bib50-20230824","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.153.11.4948","article-title":"Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2","volume":"153","year":"1994","journal-title":"J Immunol"},{"key":"bib51-20230824","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-3083.2001.00848.x","article-title":"IgG subclass profile of serum antigliadin antibodies and antibody-dependent cell-mediated cytotoxicity in young children with coeliac disease","volume":"53","year":"2001","journal-title":"Scand J Immunol"},{"key":"bib52-20230824","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.4049\/jimmunol.178.10.6590","article-title":"Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I","volume":"178","year":"2007","journal-title":"J Immunol"},{"key":"bib53-20230824","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin G subclass activity through selective Fc receptor binding","volume":"310","year":"2005","journal-title":"Science"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006842-201610000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T16:35:47Z","timestamp":1692894947000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006842-201610000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0000000000000352","relation":{},"ISSN":["1534-7796","0033-3174"],"issn-type":[{"value":"1534-7796","type":"electronic"},{"value":"0033-3174","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}